Vestor Capital LLC Has $9.98 Million Stake in Becton, Dickinson and Company (BDX)

Vestor Capital LLC increased its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 5.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,951 shares of the medical instruments supplier’s stock after acquiring an additional 2,623 shares during the period. Becton, Dickinson and makes up about 2.2% of Vestor Capital LLC’s portfolio, making the stock its 16th largest holding. Vestor Capital LLC’s holdings in Becton, Dickinson and were worth $9,984,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Becton, Dickinson and by 8.5% in the 2nd quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock valued at $3,366,809,000 after buying an additional 1,353,780 shares in the last quarter. BlackRock Inc. lifted its stake in Becton, Dickinson and by 2,427.8% in the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after buying an additional 15,887,611 shares in the last quarter. State Street Corp lifted its stake in Becton, Dickinson and by 3.5% in the 2nd quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock valued at $2,003,834,000 after buying an additional 342,873 shares in the last quarter. Northern Trust Corp lifted its stake in Becton, Dickinson and by 4.0% in the 2nd quarter. Northern Trust Corp now owns 2,813,937 shares of the medical instruments supplier’s stock valued at $549,028,000 after buying an additional 106,966 shares in the last quarter. Finally, Fiera Capital Corp lifted its stake in Becton, Dickinson and by 7.1% in the 2nd quarter. Fiera Capital Corp now owns 2,782,146 shares of the medical instruments supplier’s stock valued at $542,825,000 after buying an additional 183,372 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

A number of research analysts recently weighed in on BDX shares. BidaskClub lowered shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research note on Wednesday, August 9th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $213.00 price target on shares of Becton, Dickinson and in a research note on Tuesday, September 12th. Cowen and Company reissued a “buy” rating and issued a $230.00 target price on shares of Becton, Dickinson and in a research note on Monday, August 14th. Finally, Zacks Investment Research raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 target price on the stock in a research note on Tuesday, October 31st. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $217.08.

In other news, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the sale, the insider now owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Stephen Sichak sold 11,787 shares of Becton, Dickinson and stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the completion of the sale, the insider now owns 14,038 shares of the company’s stock, valued at approximately $2,814,057.48. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by insiders.

Becton, Dickinson and Company (BDX) traded down $3.71 during mid-day trading on Wednesday, hitting $223.12. 636,519 shares of the stock traded hands, compared to its average volume of 1,323,648. The stock has a market cap of $50,405.64, a price-to-earnings ratio of 23.34, a PEG ratio of 1.73 and a beta of 1.04. The company has a current ratio of 5.56, a quick ratio of 5.01 and a debt-to-equity ratio of 1.48. Becton, Dickinson and Company has a 1 year low of $161.29 and a 1 year high of $227.50.

Becton, Dickinson and (NYSE:BDX) last released its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.37 by $0.03. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.12 EPS. sell-side analysts forecast that Becton, Dickinson and Company will post 10.63 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 8th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, December 7th. This is a positive change from Becton, Dickinson and’s previous quarterly dividend of $0.73. Becton, Dickinson and’s payout ratio is presently 62.80%.

WARNING: This article was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://sportsperspectives.com/2017/11/22/vestor-capital-llc-has-9-98-million-stake-in-becton-dickinson-and-company-bdx.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply